Bioequivalence issue irks domestic makers

Published: 2008-06-27 07:00:00
Updated: 2008-06-27 07:00:00
Korean pharmaceutical manufacturers are again concerned about the possible impact of generic drugs’ bioequivalence data fabrication, which has been raised by the National Health Insurance Corporation.

Their reaction came when the NHIC said on June 23 it will file a civil suit against local 92 ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.